Four Federal Efforts to Monitor, Including RESULTS Act Progress
Other proposals aim to increase fraud enforcement, temper prior authorization, and modernize CLIA
Already a member? Log in here
National Lab Reporter
Keeps You Up-to-Date on Federal & State Laws, Regulations, New Legislation, and Court Cases that Affect Your Diagnostic Lab or Pathology Practice
Subscribe today for access to
Articles and Reports
FDA Watch: New RAPID Coverage Pathway Would Enable Some Lab Tests to Pursue Clearance and Medicare Coverage Simultaneously
FDA-CMS collaboration aims to accelerate Medicare coverage determinations of certain medical devices
Already a member? Log in here
RCM Strategies to Explore for Genetic Testing Compliance
Expert Ashley Zarling details nuances for clinical lab directors and compliance teams
Already a member? Log in here
Upcoming G2 Conferences
...
Already a member? Log in here
HHS Seeks Dismissal of CCLA Lawsuit on Coverage Decisions
...
Already a member? Log in here
Massachusetts Targets Self-Referral of Laboratory Services
...
Already a member? Log in here
Debate Continues Over FDA Regulation of LDTs
...
Already a member? Log in here
New Webinar
...
Already a member? Log in here
Colon Cancer Screening Test Gets FDA Approval, Proposed Medicare Coverage
...
Already a member? Log in here
FDA Plans to Regulate Lab-Developed Tests Could Increase Time and Cost of Development
In its July 31 notice to Congress, the agency says it would phase in oversight requirements over nine years.
Already a member? Log in here